Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AER Bill Highlights Need For Uniform Product Labeling, Warnings – Experts

This article was originally published in The Tan Sheet

Executive Summary

Several experts highlighted an increased need for appropriate and uniform safety and warning labeling on dietary supplement products at a recent United Natural Products Alliance seminar on implementing the Dietary Supplement and Nonprescription Drug Consumer Protection Act

You may also be interested in...



Patients With Kidney Problems High-Users Of OTCs, Supplements, Study Finds

"The use of over-the-counter medications and natural products is highly prevalent in patients with chronic renal insufficiency and often is associated with drug-related problems," a study published in the February American Journal of Kidney Diseases concludes

Patients With Kidney Problems High-Users Of OTCs, Supplements, Study Finds

"The use of over-the-counter medications and natural products is highly prevalent in patients with chronic renal insufficiency and often is associated with drug-related problems," a study published in the February American Journal of Kidney Diseases concludes

Patients With Kidney Problems High-Users Of OTCs, Supplements, Study Finds

"The use of over-the-counter medications and natural products is highly prevalent in patients with chronic renal insufficiency and often is associated with drug-related problems," a study published in the February American Journal of Kidney Diseases concludes

Topics

UsernamePublicRestriction

Register

PS100219

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel